RUJA: Repositorio Institucional de Producción Científica

 

Synthesis and characterization of different sodium hyaluronate nanoparticles to transport large neurotherapheutic molecules through blood brain barrier after stroke

dc.contributor.authorPeralta, Sebastián
dc.contributor.authorBlanco-Ruiz, Santos
dc.contributor.authorHernández-Cobo, Raquel
dc.contributor.authorCastán, Herminia
dc.contributor.authorSiles, Eva
dc.contributor.authorMartínez-Lara, Esther
dc.contributor.authorMorales-Hernández, María Encarnación
dc.contributor.authorPeinado-Herreros, María Ángeles
dc.contributor.authorRuiz-Martínez, María Adolfina
dc.date.accessioned2024-01-31T23:12:37Z
dc.date.available2024-01-31T23:12:37Z
dc.date.issued2019
dc.description.abstractSome biological drugs with proven neuroprotective capacity are unable to cross the blood brain barrier (BBB), preventing its use in neuroregenerative diseases such as stroke. The use of nanoparticles as a delivery system to transport large therapeutic molecules to the cerebral parenchyma may be a good option to overcome this limitation. To achieve this goal, we have designed some polymer nanoparticles (NPs) by two ionic gelation methods of synthesis: external (M1) and internal (M2), both using sodium hyaluronate (SH) as polymer but with differences in the elaboration of their core. Additionally, both SH-NPs were coated with chitosan and glycerol tripalmitin in order to improve their penetration capabilities into cells. The nanoparticles were characterized by size, shape and charge. Then, an experimental approach was carried out in animals submitted to a stroke model, where NPs penetration into the brain was studied and analysed after its systemic administration. All types of NPs assayed were able to cross the BBB and were endocytosed by neurons; however, the SH-NPs obtained by M2 are lightly more efficient in the rate of penetration than those obtained by M1. There were not visible differences between coated and non-coated NPs obtained by both gelation methods. This may be due to the fact that not only the size, shape and charge of NPs, but also its chemical structure influences its cellular capture by endocytic mechanisms.
dc.identifier.issn0014-3057es_ES
dc.identifier.otherhttps://doi.org/10.1016/j.eurpolymj.2019.01.030es_ES
dc.identifier.urihttps://hdl.handle.net/10953/1820
dc.language.isoenges_ES
dc.publisherPergamon-Elsevier Science LTDes_ES
dc.relation.ispartofEur. Polym. J. [2019];[112]:[433-441]es_ES
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subjectSodium hyaluronatees_ES
dc.subjectNanoparticleses_ES
dc.subjectBlood brain barrieres_ES
dc.subjectDrugs delivery systemes_ES
dc.subjectStrokees_ES
dc.titleSynthesis and characterization of different sodium hyaluronate nanoparticles to transport large neurotherapheutic molecules through blood brain barrier after strokees_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.type.versioninfo:eu-repo/semantics/publishedVersiones_ES

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
AIN019 · Peralta et al. Q1 JCR · 2019.pdf
Tamaño:
2.58 MB
Formato:
Adobe Portable Document Format
Descripción:
0014-3057/ © 2019 Published by Elsevier Ltd.

Bloque de licencias

Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.98 KB
Formato:
Item-specific license agreed upon to submission
Descripción:

Colecciones